LBBB and Myocardial Infarction on ECG
When LBBB Suggests Acute MI
LBBB should be considered indicative of acute myocardial infarction when concordant ST-segment elevation ≥1 mm is present in leads with positive QRS deflections (Sgarbossa criteria), which has >90% specificity for ongoing MI with an occluded infarct artery. 1, 2
Specific ECG Changes Indicating MI in LBBB
High-Specificity Findings (Sgarbossa Criteria)
The following ECG changes are highly specific (>90%) for acute MI in the presence of LBBB 2, 3:
- Concordant ST-segment elevation ≥1 mm in leads with positive QRS deflections (sensitivity 73%, specificity 92%) 3
- ST-segment depression ≥1 mm in leads V1-V3 (sensitivity 25%, specificity 96%) 3
- Excessive discordant ST-segment elevation ≥5 mm opposite to the QRS direction (sensitivity 19%, specificity 82%) 3
Additional Supportive Findings
- Marked ST abnormalities beyond what is expected from LBBB alone suggest acute ischemia 1
- Dynamic ST-segment changes on serial ECGs (obtained at 15-30 minute intervals) strongly support acute MI 1, 4
- New LBBB (confirmed by comparison with prior ECG) in the setting of chest pain raises high suspicion for acute MI 1
Clinical Context Requirements
LBBB alone is insufficient for MI diagnosis and requires clinical correlation 2:
- Chest pain lasting >20 minutes not responding to nitroglycerin 1
- Elevated cardiac biomarkers (troponin positive 1-2 hours after symptom onset) confirm the diagnosis 1, 5
- Atypical presentations including nausea, shortness of breath, fatigue, or syncope (seen in up to 30% of STEMI patients) 1
Critical Management Pitfalls
Common Errors to Avoid
- Do not wait for "perfect" ECG criteria - the Sgarbossa criteria have low sensitivity (10% in some studies) and should not be used to rule out MI 6, 7
- Do not assume all LBBB patients have MI - most LBBB patients in the emergency department do not have acute coronary occlusion 1
- Do not rely solely on discordant ST elevation - this finding is neither sensitive nor specific for MI 7
Recommended Diagnostic Approach
- Obtain 12-lead ECG within 10 minutes of first medical contact 1, 2
- Compare with prior ECG if available to determine if LBBB is new 1
- Apply Sgarbossa criteria - if positive, treat as STEMI equivalent 2, 3
- Perform serial ECGs at 15-30 minute intervals if initial ECG is non-diagnostic but clinical suspicion remains high 1, 8
- Obtain point-of-care troponin 1-2 hours after symptom onset to aid decision-making 1
- Consider emergency coronary angiography for patients with clinical suspicion of ongoing ischemia, new or presumed new LBBB, and positive biomarkers 1
Reperfusion Therapy Decision
In patients with clinical suspicion of ongoing MI and new or presumed new LBBB, reperfusion therapy should be initiated promptly, preferably with primary PCI (target door-to-device time ≤90 minutes) or fibrinolytic therapy if PCI unavailable, especially within 3 hours of symptom onset. 1, 2, 3
This aggressive approach is justified because 1, 5:
- LBBB patients have higher baseline mortality than those without bundle branch block
- These patients receive the greatest survival benefit from reperfusion therapy
- LBBB patients are historically undertreated despite their high-risk status